Large caps the best in biotech sector

Within the biotech sector we see a low diversification of the 12-months returns. Since August last year the sector is around 16 percent higher. Among the winners we find Madrigal Pharmaceuticals, Mirati Therapeutics and Uniqure NV. Relatively big losses were for TESARO, ACADIA Pharmaceuticals and Portola Pharmaceuticals.

Core figures biotech sector

The large caps in this sector are the winners. Among the less performing we see mostly the microcaps.

Lowest PE-ratios biotech sector

Regarding the price/earings-ratios we see a diversified palette. The large caps are with the price/earnings-ratio of 63 the most expensive. The smallcaps are the cheapest and trade at -5 times the earnings per share. Neurocrine Biosciences, Alkermes and Vanda Pharmaceuticals are the stocks with the highest ratios. Stocks with the lowest ratios are United Therapeutics, Gilead Sciences and Syneos Health.

Highest dividend yields biotech sector

The sector's average dividend yield is with 0,2 percent relatively limited. Stocks with now high dividend yields are Regenxbio, Gilead Sciences and Lonza AG.

This is a free publication from Valuespectrum Pro. Valuespectrum Pro is a professional platform with analyses from all US and European companies. Click here to sign up for free.